trend

Gome Fin Tech Announced Annual Results of 2023

Source Node:
Time Stamp: April 1, 2024 1:23 PM - Modified On: April 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Commercial Factoring Progresses Despite Stability Diversified Businesses Ready for Development HONG KONG, Mar 29, 2024 - (ACN Newswire) - Gome Finance Technology Co., Ltd.(Stock Code:628.HK,“Gome Fin Tech”or “the Company”,with its subsidiaries,the“Group”), announced its audited annual results for the year ended 31 December, 2023 (the “Reporting Period”). In 2023, the global geopolitical risks are frequent, the lack of economic recovery momentum and the widening trend of differentiation among countries are highlighted, and the risk spillover from European and US banks under the global high interest rate environment also casts a

Simplifying and Elevating GraphQL to New Heights: Grafbase’s Strategic Leap in Enterprise Adoption

Source Node:
Time Stamp: March 7, 2024 12:24 PM - Modified On: March 7, 2024 - Published By:
Source Cluster:
Republished By Plato

~ Grafbase is leading the GraphQL revolution by providing a modern developer experience for building and deploying high-performance APIs. ~ With the advent of Federated Graphs, Grafbase allows composing multiple, independently deployed GraphQL APIs into a single endpoint. ~ The platform sets new standards in the GraphQL ecosystem with TypeScript SDK, Edge Caching, advanced security, real-time analytics, and more. March 2024: According to a report by Gartner, the adoption of GraphQL has been on an increasing trend, from less than 10% in 2021 to over 50% by 2025. Demand for

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

Source Node:
Time Stamp: January 29, 2024 6:55 AM - Modified On: January 29, 2024 - Published By:
Source Cluster:
Republished By Plato

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

Walking the Tightrope

Source Node:
Time Stamp: November 15, 2023 5:02 AM - Modified On: November 15, 2023 - Published By:
Source Cluster:
Republished By Plato

As we stand on the verge of a new era in crypto, it’s crucial to reaffirm the importance of decentralization. Beyond being a mere aspiration, decentralization serves as the lifeblood of the crypto world, standing as the pivotal force that draws the line between freedom and control. Amidst the hype surrounding the impending approval of a spot Bitcoin ETF in the United States, accompanied by the influx of capital from behemoths like BlackRock, the immediate market surge raises a serious question for the future of crypto. Are people here for

HealthCare AI: The Unavoidable Revolution in Modern Medicine

Source Node:
Time Stamp: October 5, 2023 3:39 PM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Rocket Raccoon: A Phenomenon of Memecoin Magic and the Pursuit of Financial Liberation

Source Node:
Time Stamp: May 19, 2023 4:15 PM - Modified On: May 19, 2023 - Published By:
Source Cluster:
Republished By Plato

In the ever-evolving world of cryptocurrencies, a remarkable phenomenon has captured the imagination of both seasoned investors and enthusiasts alike. This captivating tale revolves around the rise of a viral memecoin, where a charismatic raccoon character named Rocket has taken centre stage. Welcome to the intriguing world of Degen RocketRacoon. Drawing inspiration from the Marvel Cinematic Universe, particularly the beloved Guardians of the Galaxy franchise, Degen RocketRacoon seeks to deliver an electrifying rush that crypto investors crave. Despite its stealthy launch, this audacious project has swiftly captured public attention, boasting

Paribus. Trust Less.

Source Node:
Time Stamp: May 3, 2023 4:37 AM - Modified On: May 3, 2023 - Published By:
Source Cluster:
Republished By Plato

One month ago, Jerome Powell, head of the Federal Reserve in the US, announced that the banking system was sound and robust despite the collapse of several large banks. After raising rates a further 0.25%, he said, “We’re committed to learning the lessons from this episode and to work to prevent events like this from happening again.” As we prepare for another potential 0.25% rate hike on May 3rd, another major bank in the US, First Republic Bank, has collapsed. Its collapse is part of a larger trend of consolidation